P.S. I feel your pain on doing these kinds of submission.
-
You can use human metagenome or other metagenome for the taxonomy field in BioSample. Here's some examples we have done, you probably need to tweak things:
P.S. I feel your pain on doing these kinds of submission. -
Having not submitted similar data I am not 100% sure what exactly it is that you need to do. Can you post an example and the final result you want?
Clearly this problem must have been faced by others before. Nothing seems to come up in searches though.Leave a comment:
-
Should you not be submitting this data via the short read archive (http://www.ncbi.nlm.nih.gov/books/NBK47529/) rather than GenBank (https://www.ncbi.nlm.nih.gov/guide/h...quence-data/)?Leave a comment:
-
Need help with a GenBank submission
Hello everyone,
New to the forum, but I have a question which I hope someone can help me with. I am trying to submit to GenBank Roche 454 16S sequences but is having a small problem. We used the pipeline QIIME for our alignment etc. However, when you submit to GenBank, you need at least the sequence and the organism name. The QIIME pipeline is a bit different. It generates a sequence file and then a phylogeny file which is matched by an identifier. My problem is that I have at least 122,000 sequences. It is nearly impossible for me to perform this manually. This is probably easiest done via a script of some sort (unfortunately I have no script writing ability).
Does anyone know of any open sourced software or of any other programs I could use to resolve this problem. We have already submitted the paper so submitting the sequences is a high priority (I didn't expect it to be this difficult).
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Leave a comment: